Our CEO, David Weinkove, discusses the use of C. elegans and how they could be used in the field of Geroscience to accelerate the drug development process.
Pharmaceutical company Lundbeck in collaboration with Magnitude Biosciences on innovative new platform to test interventions for neurodegenerative disease
Lundbeck collaborates with Magnitude on innovate platform to test neurodegenerative disease interven...Read More